These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19786759)

  • 1. Severe acute ulcerative colitis: the pediatric perspective.
    Turner D
    Dig Dis; 2009; 27(3):322-6. PubMed ID: 19786759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response.
    Turner D; Mack D; Leleiko N; Walters TD; Uusoue K; Leach ST; Day AS; Crandall W; Silverberg MS; Markowitz J; Otley AR; Keljo D; Mamula P; Kugathasan S; Hyams J; Griffiths AM
    Gastroenterology; 2010 Jun; 138(7):2282-91. PubMed ID: 20193683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current management of severe ulcerative colitis.
    Caprilli R; Viscido A; Latella G
    Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):92-101. PubMed ID: 17268544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
    Lees CW; Heys D; Ho GT; Noble CL; Shand AG; Mowat C; Boulton-Jones R; Williams A; Church N; Satsangi J; Arnott ID;
    Aliment Pharmacol Ther; 2007 Aug; 26(3):411-9. PubMed ID: 17635376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis.
    Fanjiang G; Russell GH; Katz AJ
    J Pediatr Gastroenterol Nutr; 2007 Mar; 44(3):312-7. PubMed ID: 17325550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
    Kohn A; Daperno M; Armuzzi A; Cappello M; Biancone L; Orlando A; Viscido A; Annese V; Riegler G; Meucci G; Marrollo M; Sostegni R; Gasbarrini A; Peralta S; Prantera C
    Aliment Pharmacol Ther; 2007 Sep; 26(5):747-56. PubMed ID: 17697208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of acute severe ulcerative colitis.
    Van Assche G; Vermeire S; Rutgeerts P
    Gut; 2011 Jan; 60(1):130-3. PubMed ID: 21030524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome following infliximab therapy in children with ulcerative colitis.
    Hyams JS; Lerer T; Griffiths A; Pfefferkorn M; Stephens M; Evans J; Otley A; Carvalho R; Mack D; Bousvaros A; Rosh J; Grossman A; Tomer G; Kay M; Crandall W; Oliva-Hemker M; Keljo D; LeLeiko N; Markowitz J;
    Am J Gastroenterol; 2010 Jun; 105(6):1430-6. PubMed ID: 20104217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe ulcerative colitis: differences in elderly patients?
    Vavricka SR; Rogler G
    Dig Dis; 2009; 27(3):315-21. PubMed ID: 19786758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
    Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to the management of refractory ulcerative colitis.
    Sonu I; Blonski W; Lin MV; Lichtenstein GR
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):213-31. PubMed ID: 20485258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute severe ulcerative colitis in children: a systematic review.
    Turner D; Griffiths AM
    Inflamm Bowel Dis; 2011 Jan; 17(1):440-9. PubMed ID: 20645317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab for ulcerative colitis in children and adolescents.
    McGinnis JK; Murray KF
    J Clin Gastroenterol; 2008 Sep; 42(8):875-9. PubMed ID: 18645529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.
    Maser EA; Deconda D; Lichtiger S; Ullman T; Present DH; Kornbluth A
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1112-6. PubMed ID: 18928936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of acute severe ulcerative colitis.
    Doherty GA; Cheifetz AS
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):395-405. PubMed ID: 19673626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
    Jakobovits SL; Jewell DP; Travis SP
    Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis.
    Cacheux W; Seksik P; Lemann M; Marteau P; Nion-Larmurier I; Afchain P; Daniel F; Beaugerie L; Cosnes J
    Am J Gastroenterol; 2008 Mar; 103(3):637-42. PubMed ID: 18047542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.
    Russo EA; Harris AW; Campbell S; Lindsay J; Hart A; Arebi N; Milestone A; Tsai HH; Walters J; Carpani M; Westaby D; Thillainayagam A; Bansi D; Ghosh S
    Aliment Pharmacol Ther; 2009 Feb; 29(3):308-14. PubMed ID: 19035973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.